BKFAF — BROOKFIELD Corp /ON/

NYSE · Real Estate · Equity Real Estate Investment Trusts (REITs) · CIK 1001085 ·
Last close
$8.00
Market Cap
52W High
$8.00
52W Low
$7.81
ADV30
0
Next earnings
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of patients with idiopathic pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 18,580,000,000 4,442,000,000 4,422,000,000 102,000,000 519,613,000,000 15,030,000,000 353,971,000,000
Dec 2025 20,156,000,000 5,180,000,000 5,158,000,000 743,000,000 518,971,000,000 16,242,000,000 352,777,000,000
Sep 2025 18,917,000,000 4,285,000,000 4,267,000,000 219,000,000 514,586,000,000 16,682,000,000 351,506,000,000
Jun 2025 18,083,000,000 4,168,000,000 4,148,000,000 272,000,000 506,068,000,000 13,703,000,000 344,423,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$10,958,000,000
Investing CF
$-31,777,000,000
Financing CF
$21,687,000,000
CapEx
$-14,752,000,000
Dividends Paid
$-719,000,000
Buybacks
$-755,000,000
EPS Diluted TTM
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$16,665,000,000
Inventory
$5,923,000,000
Receivables
$22,772,000,000
ST Investments
$7,362,000,000
EBIT TTM
$21,470,000,000
Pretax Income TTM
$4,370,000,000
Interest Exp TTM
$17,100,000,000
Analysts

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 75,100,000,000 18,049,000,000 1,307,000,000 518,971,000,000 352,777,000,000 10,958,000,000
Dec 2024 86,006,000,000 17,994,000,000 641,000,000 490,424,000,000 325,041,000,000 7,569,000,000
Dec 2023 95,924,000,000 14,446,000,000 1,130,000,000 490,095,000,000 321,853,000,000 6,467,000,000
Dec 2022 92,769,000,000 14,136,000,000 2,056,000,000 441,284,000,000 299,393,000,000 8,751,000,000

Peers — same industry

TickerNameMarket CapLastDaily %
WELL WELLTOWER INC. $168.93B $234.44
PLD Prologis, Inc. $134.93B $144.61
EQIX EQUINIX INC $100.57B $1019.28
BN BROOKFIELD Corp /ON/ $94.99B $42.53
AMT AMERICAN TOWER CORP /MA/ $80.78B $173.36

News headlines (Yahoo Finance, 1h cache)

Westinghouse IPO Could Be America’s Biggest Nuclear Offering Yet
2026-07-31 18:18 · Yahoo
Blackstone Inc. (BX)’s Profit Jumped 26% on AI Bets but the Stock Barely Moved. Here’s Why.
2026-07-30 14:46 · Yahoo
Nvidia’s $750 Billion Deals Revive Fear of AI Circular Financing
2026-07-27 10:20 · Yahoo
Nvidia to Invest $1 Billion in Naver and Expand SK Group Accord
2026-07-24 23:58 · Yahoo
Brookfield (TSX:BN) Stock Still Looks Expensive Despite Its $180b Insurance Push
2026-07-17 23:08 · Yahoo
Billionaire Investor Bill Ackman’s Top 5 Bets: Buy, Hold, or Steer Clear?
2026-07-17 20:08 · Yahoo
Brookfield (TSX:BN) Simplifies Its Structure, Is The Premium Valuation Fully Priced?
2026-07-17 11:12 · Yahoo
Brookfield Shareholders Back New BN Deal as Firm Targets 20% Earnings Growth
2026-07-17 02:02 · Yahoo
Brookfield Wealth Solutions Announces Shareholder Approval of Transaction to Simplify Corporate Structure and Results of 2026 Annual General and Special Meeting
2026-07-17 00:31 · Yahoo
Brookfield Announces Shareholder Approval of Transaction to Simplify Corporate Structure and Results of 2026 Annual and Special Meeting
2026-07-17 00:27 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.